ASPEN, CO — America’s biopharmaceutical companies released a new virtual reality video highlighting innovation and a new era of groundbreaking advancements today to kick off Spotlight Health, the opening segment of the annual 2017 Aspen Ideas Festival.
The 360° immersive video experience takes viewers inside a biopharmaceutical lab, where amazing discoveries are being made in science through the use of genomics-based research. The video provides valuable insights into the real-life laboratory experience happening every day, and how the new era of medicine is helping power scientific advancements that improve patient lives.
The video is part of GOBOLDLY, a multi-year national campaign showcasing the work of industry researchers who are driving cutting-edge advances in science.
Representatives from Pharmaceutical Research and Manufacturers of America (PhRMA) will be available to speak to the industry’s efforts in pioneering new treatments and the future of medicine, along with other health policy issues. Members of the media are welcome to visit the exhibit and check out the 360° video during the Spotlight Health conference.
America’s Biopharmaceutical Companies’ GoBoldly Exhibit & 360° Video Experience
Thursday June 22 from 8:30 am – 5:00 pm
Friday June 23 from 8:30 am – 5:00 pm
Saturday June 24 from 8:30 am – 5:00 pm
The East Lawn (across the street from the Paepcke Memorial Building)
Representatives from PhRMA will be available for interviews while onsite. Please direct all interview requests to firstname.lastname@example.org.
FOR YOUR RADAR:
In addition to the exhibit for America’s biopharmaceutical companies, Stephen J. Ubl, President & CEO of PhRMA, will participate in a panel discussion Friday morning June 23rd examining the value medicines bring patients and how payment and delivery systems can meet 21st century demands.
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives. Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.